[HTML][HTML] Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection

BK Patterson, EB Francisco, R Yogendra… - Frontiers in …, 2022 - frontiersin.org
The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the
recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 …

[HTML][HTML] Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning

…, J Guevara-Coto, R Yogendra, EB Francisco… - Frontiers in …, 2021 - frontiersin.org
Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis,
consequently therapeutics directed against CCR5 are being investigated. Here, we …

[HTML][HTML] CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

…, APS Pang, C Sugai, E Mahyari, EB Francisco… - International Journal of …, 2021 - Elsevier
Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

[HTML][HTML] Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

F Moisan, EB Francisco, A Brozovic, GE Duran… - Molecular …, 2014 - Elsevier
Ovarian cancer is associated with a leukocyte infiltrate and high levels of chemokines such
as CCL2. We tested the hypothesis that CCL2 inhibition can enhance chemotherapy with …

Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19

…, J Lalezari, APS Pang, C Sugai, EB Francisco… - MedRxiv, 2020 - medrxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is now pandemic with nearly three million cases …

[HTML][HTML] SARS-CoV-2 S1 protein persistence in SARS-CoV-2 negative post-vaccination individuals with long COVID/PASC-like symptoms

BK Patterson, EB Francisco, R Yogendra, E Long… - 2022 - europepmc.org
Background: We sought to determine the immunologic abnormalities in patients following
SARS-CoV-2 vaccines who experience post-acute sequelae of COVID-19 (PASC)-like …

[HTML][HTML] Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions

BK Patterson, J Guevara-Coto, EB Francisco… - 2022 - europepmc.org
Background: Post-acute sequelae of COVID-19 (PASC) is a growing healthcare and economic
concern affecting as many as 10%-30% of those infected with COVID-19. Though the …

Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome

RJ Coffey, TS Edgar, GE Francisco, V Graziani… - Archives of physical …, 2002 - Elsevier
Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA,
Turner MS. Abrupt withdrawal from intrathecal baclofen: recognition and management of a …

Long COVID Diagnostic with Differentiation from Chronic Lyme Disease using Machine Learning and Cytokine Hubs

B Patterson, J Guevara-Coto, J Mora, EB Francisco… - 2024 - researchsquare.com
The absence of a diagnostic for long COVID (LC) or post-acute sequelae of COVID-19 (PASC)
has profound implications for research and potential therapeutics. Further, symptom-…

Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome

…, KA Edgar, E Howie, K Killpack, B Milash… - Nature …, 2004 - nature.com
In fruit fly research, chromosomal deletions are indispensable tools for mapping mutations,
characterizing alleles and identifying interacting loci. Most widely used deletions were …